5-Fluoro-EPT

In this article we will delve into 5-Fluoro-EPT, a topic of great relevance today. 5-Fluoro-EPT is a point of interest that has captured the attention of experts, academics and the general public due to its impact on various aspects of daily life. Through detailed analysis and exhaustive exploration of its different aspects, we seek to better understand the implications of 5-Fluoro-EPT in today's world. Furthermore, we will examine its evolution over time and its influence in different fields, in order to offer a comprehensive vision that enriches the debate around this topic. Without a doubt, 5-Fluoro-EPT is a topic that arouses great interest and controversy, so it is essential to address it with the seriousness and depth it deserves.

5-Fluoro-EPT
Identifiers
  • N-ethyl-N-propan-1-amine
CAS Number
PubChem CID
ChemSpider
ChEMBL
Chemical and physical data
FormulaC15H21FN2
Molar mass248.345 g·mol−1
3D model (JSmol)
  • CCCN(CC)CCC1=CNC2=C1C=C(C=C2)F
  • InChI=1S/C15H21FN2/c1-3-8-18(4-2)9-7-12-11-17-15-6-5-13(16)10-14(12)15/h5-6,10-11,17H,3-4,7-9H2,1-2H3
  • Key:QONMHCQBCANXJS-UHFFFAOYSA-N

5-Fluoro-EPT (5F-EPT, 5-fluoro-N-ethyl-N-propyltryptamine) is a psychedelic tryptamine derivative related to drugs such as EPT and 5-MeO-EPT. It acts as a potent full agonist at the 5-HT2A receptor with an EC50 of 5.54 nM and an efficacy of 104% (compared to serotonin). It produces a head-twitch response in animal studies, and is claimed to have antidepressant activity.[1]

See also

References

  1. ^ WO 2021/168082, Kruegel AC, Sporn J, "Specific Tryptamines for use in the Treatment of Mood Disorders.", published 26 August 2021, assigned to Gilgamesh Pharmaceuticals, Inc..